Linda C. Hogan, Head, Business Development and Strategy at CoLucid Pharmaceuticals, Inc. (CLCD), sold 3,302 shares at $35.22 ($123K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Open-market sale of $123k CLCD by Head, Business Development and Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.22 | 719 | $25K | 20.6% |
| 2 | $35.22 | 719 | $25K | 20.6% |
| 3 | $38.75 | 186 | $7K | 5.9% |
| 4 | $38.75 | 1,678 | $65K | 52.9% |
| Total | $37.21 avg | 3,302 | $123K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-01 | $22K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $96K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $969K | — | Filing → |